• Yahoo Life Shopping

    'My skin is tighter and softer': Grab this popular anti-aging retinol cream for $14 — that's 40% off

    Raved a 65-year-old fan: 'I tried this lotion on one arm and did a comparison. OMG! The difference was astounding and immediate.'

  • Local Journalism Initiative

    Kaslo residents gather for FireSmart and Community Wildfire Resiliency Plan open house

    On the evening of Wednesday, April 3, about 20 Kaslo residents gathered for an open house on the Kaslo FireSmart Program and the Kaslo & Area D Community Wildfire Resiliency Plan (CWRP). Presenters included Jessie Lay, Kaslo’s FireSmart coordinator, John Cathro and Mark Elder, professional foresters, and Jeff Reyden, co-manager of the Kaslo & District Community Forest Society. Representatives from the Kaslo Volunteer Fire Department attended, including new fire chief, Eric Graham. Grace Kyle, BC

  • Reuters

    India's Biocon developing its own version of Wegovy, clinical trial likely next year

    Indian drugmaker Biocon, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's wildly popular Wegovy and is prepared to conduct a clinical trial next year if needed, the CEO told Reuters. Wall Street has forecast the market for this new generation of obesity treatments reaching at least $100 billion by the end of the decade, and Biocon is taking steps to be a part of that windfall. "We're going to develop semaglutide for India even if it requires a clinical trial," Chief Executive Officer Siddharth Mittal said in an interview of the active ingredient in Wegovy and Ozempic.